Traws Pharma (TRAW) News Today $5.51 -0.64 (-10.41%) Closing price 04:00 PM EasternExtended Trading$5.56 +0.06 (+1.00%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Traws Pharma files to sell 7.23M shares of common stock for holdersJanuary 16, 2025 | markets.businessinsider.comTraws stock rallies 24% on avian flu drug updateJanuary 10, 2025 | msn.comTraws Pharma, Expert Systems: Breakthrough in H5N1Bird Flu antiviral programJanuary 10, 2025 | msn.comExpert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral ProgramJanuary 10, 2025 | prnewswire.comTraws Pharma Secures $72.6 Million for Bird Flu Treatment DevelopmentJanuary 4, 2025 | msn.comTraws stock plunges 43% on financing updateDecember 30, 2024 | msn.comTraws Pharma announces $72.6M financingDecember 30, 2024 | markets.businessinsider.comBucks County firm's shares plunge on capital raise planDecember 30, 2024 | bizjournals.comTraws Pharma Announces Financing By Investors - Quick FactsDecember 30, 2024 | markets.businessinsider.comTraws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to ApprovalDecember 30, 2024 | prnewswire.comTraws Pharma Inc trading halted, volatility trading pauseDecember 29, 2024 | markets.businessinsider.comTraws Pharma, Inc. (TRAW)December 27, 2024 | finance.yahoo.comTraws Pharma announces progress in the development of tivoxavir marboxilDecember 24, 2024 | markets.businessinsider.comTraws Pharma Inc trading resumesDecember 24, 2024 | markets.businessinsider.comTraws Pharma Stock Hits 6-Month Highs On Bird Flu Treatment Breakthrough, Retail Interest SoarsDecember 24, 2024 | msn.comWall Street Set to Open Lower Monday as Investors Look for a Year-End RallyDecember 23, 2024 | msn.comInvestors Look to Reverse Last Week's Slide as US Futures Mixed Monday Pre-BellDecember 23, 2024 | msn.comTraws Pharma Shares Surge 83% on Development of Bird Flu TreatmentDecember 23, 2024 | marketwatch.comTraws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird FluDecember 23, 2024 | prnewswire.comTraws Pharma Reports Q3 Financials and Updates on Clinical AdvancesNovember 17, 2024 | msn.comTraws Pharma Faces Uncertain Future Amid Complex Onconova MergerNovember 16, 2024 | tipranks.comTraws Pharma Reports Promising Antiviral Drug ProgressNovember 16, 2024 | markets.businessinsider.comTraws Pharma Faces Uncertain Future Amid Complex Onconova MergerNovember 16, 2024 | markets.businessinsider.comTraws Pharma Provides Business Update and Reports Q3 2024 Financial ResultsNovember 14, 2024 | globenewswire.comTraws Pharma, Inc. (NASDAQ:TRAW) Short Interest Up 652.9% in SeptemberTraws Pharma, Inc. (NASDAQ:TRAW - Get Free Report) was the recipient of a significant growth in short interest in September. As of September 30th, there was short interest totalling 12,800 shares, a growth of 652.9% from the September 15th total of 1,700 shares. Based on an average daily volume of 7,800 shares, the short-interest ratio is currently 1.6 days. Approximately 0.6% of the shares of the company are short sold.October 10, 2024 | marketbeat.comExpert Systems Celebrates Milestone in Clinical Development of Tivoxavir Marboxil, Potential One-Time Influenza TreatmentOctober 10, 2024 | tmcnet.comTraws Pharma Reports Positive Phase 1 Results for Influenza Therapy Tivoxavir MarboxilOctober 10, 2024 | msn.comTraws Pharma Inc (TRAW) Q2 2024 Earnings Call Highlights: Navigating Financial Challenges Amid ...October 10, 2024 | finance.yahoo.comTraws Pharma Reports Positive Topline Phase 1 Data For Flu Candidate, Tivoxavir Marboxil; Stock UpOctober 8, 2024 | markets.businessinsider.comTraws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir MarboxilOctober 8, 2024 | globenewswire.comPromising Phase 1 Results for Traws Pharma’s COVID Treatment CandidateOctober 2, 2024 | msn.comWhy Traws Pharma Is Rising In Pre-market?October 1, 2024 | markets.businessinsider.comTraws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro InhibitorSeptember 30, 2024 | globenewswire.comTraws Pharma Inc (0T20.F)September 24, 2024 | au.finance.yahoo.comOrbimed Advisors LLC Reduces Stake in Traws Pharma IncSeptember 24, 2024 | finance.yahoo.comTraws Pharma Welcomes Luba Greenwood Amid Strategic Board ChangesSeptember 21, 2024 | msn.comTraws Pharma, Inc. Appoints Luba Greenwood to Board of DirectorsSeptember 20, 2024 | globenewswire.comTraws Pharma Announces Key Approvals and Reverse Stock Split at 2024 Special MeetingSeptember 20, 2024 | msn.comTRAWS PHARMA INC. DL-,01 (0T2.DU)September 19, 2024 | au.finance.yahoo.comMantle Cell Lymphoma Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsightSeptember 19, 2024 | finance.yahoo.comDelveInsight Business Research, LLP: Mantle Cell Lymphoma Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsightSeptember 19, 2024 | finanznachrichten.deTraws Pharma, Inc. Announces Special Shareholders Meeting ResultsSeptember 17, 2024 | globenewswire.comTraws Pharma, Inc. (TRAW) Corporate Update Call TranscriptAugust 20, 2024 | seekingalpha.comTraws Pharma, Inc.: Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business HighlightsAugust 15, 2024 | finanznachrichten.deTraws Pharma Reports Q2 2024 Financial Results, Provides Recent Business HighlightsAugust 15, 2024 | finance.yahoo.comTraws Pharma Reports Q2 2024 Financial Results, Provides Recent Business HighlightsAugust 15, 2024 | globenewswire.comTraws Pharma Inc TRAWAugust 9, 2024 | morningstar.comTraws Pharma Inc (TRAW)July 25, 2024 | uk.investing.com0T2.SG,0P0000ZC8L,0 (0T2.SG)July 19, 2024 | finance.yahoo.com Get Traws Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for TRAW and its competitors with MarketBeat's FREE daily newsletter. Email Address TRAW Media Mentions By Week TRAW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRAW News Sentiment▼0.590.60▲Average Medical News Sentiment TRAW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRAW Articles This Week▼11▲TRAW Articles Average Week Get Traws Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for TRAW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Adverum Biotechnologies News Today I-Mab News Today Entera Bio News Today Genenta Science News Today Scilex News Today Skye Bioscience News Today Karyopharm Therapeutics News Today Cue Biopharma News Today Genelux News Today bluebird bio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TRAW) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Traws Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Traws Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRAW Stock Alerts